In contrast to other mutations such as TET2 and DNMT3A, which can occur in both tumor and nontumor cells of AITL patients, RHOA mutations appear to be limited to tumor cells, indicating that they play an important role in AITL pathogenesis (67, 88). The gene discussed is RHOA; the disease is angioimmunoblastic T-cell lymphoma.